K12 Thalidomide: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
{{Header}} | {{Header}} | ||
[[K12 Professional Development 2016]] | [[K12 Professional Development 2016]] | ||
{| class="wikitable mw-collapsible mw-collapsed" | |||
! Teacher Note | |||
|- | |||
| colspan="2"|[[File:Mark_Hill.jpg|50px]] This is currently only a draft designed to help K12 students understand the drug thalidomide. | |||
Below are links to more detailed pages that are designed for university level students, that would also be valuable for teacher reference. | |||
:'''Links:''' [[Abnormal_Development_-_Thalidomide|Thalidomide]] | [[Australian Drug Categories]] | |||
[[K12 Professional Development 2016]] | [[K12 Professional Development 2014]] | |||
|} | |||
{| | {| | ||
| Line 10: | Line 23: | ||
When taken during the first trimester of pregnancy, thalidomide prevented the proper growth of the fetus resulting in horrific birth defects in thousands of children around the world. This is an example for students of inadequate drug testing and a lack of understanding of environmental effects on human development. This is often cited today as a reason to have significant testing of drugs before release and classification of drugs based upon their affects on development. | When taken during the first trimester of pregnancy, thalidomide prevented the proper growth of the fetus resulting in horrific birth defects in thousands of children around the world. This is an example for students of inadequate drug testing and a lack of understanding of environmental effects on human development. This is often cited today as a reason to have significant testing of drugs before release and classification of drugs based upon their affects on development. | ||
|} | |} | ||
{{Footer}} | {{Footer}} | ||
Revision as of 16:37, 6 April 2016
Embryology - 2 Nov 2026    Expand to Translate
|
|---|
| Google Translate - select your language from the list shown below (this will open a new external page) |
|
العربية | català | 中文 | 中國傳統的 | français | Deutsche | עִברִית | हिंदी | bahasa Indonesia | italiano | 日本語 | 한국어 | မြန်မာ | Pilipino | Polskie | português | ਪੰਜਾਬੀ ਦੇ | Română | русский | Español | Swahili | Svensk | ไทย | Türkçe | اردو | ייִדיש | Tiếng Việt These external translations are automated and may not be accurate. (More? About Translations) |
K12 Professional Development 2016
| Teacher Note | |
|---|---|
 This is currently only a draft designed to help K12 students understand the drug thalidomide.
Below are links to more detailed pages that are designed for university level students, that would also be valuable for teacher reference.
K12 Professional Development 2016 | K12 Professional Development 2014 | |
Thalidomide molecular structure |
Thalidomide is a drug that was introduced on to the market on October 1, 1957 in West Germany. Thalidomide soon became a drug prescribed to pregnant women to combat symptoms associated with morning sickness.
When taken during the first trimester of pregnancy, thalidomide prevented the proper growth of the fetus resulting in horrific birth defects in thousands of children around the world. This is an example for students of inadequate drug testing and a lack of understanding of environmental effects on human development. This is often cited today as a reason to have significant testing of drugs before release and classification of drugs based upon their affects on development. |
Cite this page: Hill, M.A. (2026, November 2) Embryology K12 Thalidomide. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/K12_Thalidomide
- © Dr Mark Hill 2026, UNSW Embryology ISBN: 978 0 7334 2609 4 - UNSW CRICOS Provider Code No. 00098G
